Breathing Support Reduces Blood Pressure For People With Sleep Apnoea (p 204)January 17, 2002A reduction in blood pressure-and in the probable risk of stroke and other cardiovascular disease-could be possible for patients treated with nocturnal breathing support for sleep apnoea, conclude authors of a study in this week's issue of THE LANCET. Obstructive sleep apnoea is a serious condition in which airflow from the nose and mouth to the lungs is restricted during sleep; it is second only to asthma as a cause of chronic respiratory disease. It is characterised by loud snoring, daytime sleepiness (due to poor-quality sleep), and a fall in the oxygen concentration in blood, and is associated with increased blood pressure and a raised cardiovascular risk profile. Untreated sleep apnoea patients have about a 3% risk of a stroke or other cardiovascular event each year. An effective treatment for sleep apnoea with a breathing support device called nasal continuous positive airway pressure (nCPAP) is known to improve sleep quality, but the effects of this treatment on blood pressure are unclear. Robert Davies and colleagues from Oxford Radcliffe Hospital, UK, did a randomised trial of nCPAP, to compare the change in blood pressure in 118 men with severe obstructive sleep apnoea. Patients were assigned to either therapeutic or subtherapeutic nCPAP for one month. Subtherapeutic nCPAP involved the same breathing equipment delivering a reduced air pressure that did not affect the severity of sleep apnoea. The primary outcome was the change in 24-hour average blood pressure. Other outcomes were changes in systolic and diastolic blood pressure and pressures while the patient was asleep and awake, and relations between blood pressure changes, baseline blood pressure, and severity of sleep apnoea. Therapeutic nCPAP reduced mean arterial blood pressure by 3.3 mm Hg compared with the subtherapeutic control. This benefit was seen in both systolic and diastolic blood pressure, and during both sleep and while awake. The benefit was largest in patients with more severe sleep apnoea, and was especially substantial in patients also taking drug treatment for high blood pressure. Robert Davies comments: "We have shown a clinically important lowering of blood pressure when patients with moderate or severe obstructive sleep apnoea are given therapeutic nCPAP. This result is confirmed by comparison with a robust control and is seen in both systolic and diastolic pressure, and during both wake and sleep. As a result of this reduction we conclude that nCPAP treatment for obstructive sleep apnoea probably produces a significant reduction in the risk of stroke and other cardiovascular diseases as well as substantially improving these patients' excessive daytime sleepiness and quality of life." Lancet |
|||||||||||||||||||||
| Related Stroke Current Events and Stroke News Articles New understanding about mechanism for cell death after stroke leads to possible therapy Scientists at the Brain Research Centre, a partnership of the University of British Columbia Faculty of Medicine and Vancouver Coastal Health Research Institute, have uncovered new information about the mechanism by which brain cells die following a stroke, as well as a possible way to mitigate that damage. Surgery not linked to memory problems in older patients For years, it has been widely assumed that older adults may experience memory loss and other cognitive problems following surgery. But a new study from researchers at Washington University School of Medicine in St. Louis questions those assumptions. Pushing the brain to find new pathways Until recently, scientists believed that, following a stroke, a patient had about six months to regain any lost function. After that, patients would be forced to compensate for the lost function by focusing on their remaining abilities. Night Beat, Overtime and a Disrupted Sleep Pattern Can Harm Officers' Health A police officer who works the night shift, typically from 8 p.m. to 4 a.m., already is at a disadvantage when it comes to getting a good "night's" sleep. Vitamin B niacin offers no extra benefit to statin therapy in seniors already diagnosed with CAD The routine prescription of extended-release niacin, a B vitamin (1,500 milligrams daily), in combination with traditional cholesterol-lowering therapy offers no extra benefit in correcting arterial narrowing and diminishing plaque buildup in seniors who already have coronary artery disease, a new vascular imaging study from Johns Hopkins experts shows. The benefits of exercise Physical exercise is one of the most effective methods of preventing disease. The current issue of Deutsches Arzteblatt International is devoted to this important topic. Heart and bone damage from low vitamin D tied to declines in sex hormones Researchers at Johns Hopkins are reporting what is believed to be the first conclusive evidence in men that the long-term ill effects of vitamin D deficiency are amplified by lower levels of the key sex hormone estrogen, but not testosterone. New study links vitamin D deficiency to cardiovascular disease and death While mothers have known that feeding their kids milk builds strong bones, a new study by researchers at the Heart Institute at Intermountain Medical Center in Salt Lake City suggests that Vitamin D contributes to a strong and healthy heart as well - and that inadequate levels of the vitamin may significantly increase a person's risk of stroke, heart disease, and death, even among people who've never had heart disease. Early end to key study on benefits of niacin, a B vitamin, in keeping arteries open was premature Heart experts at Johns Hopkins are calling premature the early halt of a study by researchers at Walter Reed Army Medical Center and Washington Hospital Center on the benefits of combining extended-release niacin, a B vitamin, with cholesterol-lowering statin medications to prevent blood vessel narrowing. Study finds many people with hemianopia have difficulty detecting pedestrians while driving, advocates for individual testing Schepens Eye Research Institute scientists have found that--when tested in a driving simulator--patients with hemianopia (blindness in one half of the visual field in both eyes) have significantly more difficulty detecting pedestrians (on their blind side) than normally sighted people. More Stroke Current Events and Stroke News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||